5 of Last Week's Biggest Losers

There's never a shortage of losers in the stock market.

Let's take a closer look at five of this past week's biggest sinkers.

Company

Nov. 12

Weekly Loss

My Watchlist

Alimera Sciences (Nasdaq: ALIM  ) $1.98 (73%) Add
Primo Water (Nasdaq: PRMW  ) $3.54 (40%) Add
Rovi (Nasdaq: ROVI  ) $29.77 (38%) Add
Green Mountain Coffee Roasters (Nasdaq: GMCR  ) $43.71 (38%) Add
ATP Oil & Gas (Nasdaq: ATPG  ) $6.75 (36%) Add

Source: Barron's.

Alimera Sciences was last week's biggest dog, shedding nearly three-quarters of its value after the FDA rejected the company's flagship drug candidate, Iluvien. Upstart biotechs with thin pipelines are obviously at the mercy of regulatory approvals during the drawn-out clinical trial process.

Primo Water hosed down its near-term outlook, and its guidance for the current quarter suggests a sequential decline. The bottled-water distributor also talked down the holiday prospects of its Flavorstation home beverage system.

A few analysts downgraded Rovi after the home theater tech guru posted uninspiring quarterly results. Rovi also issued 2012 guidance that's well short of the top-line growth that Wall street was forecasting.

Green Mountain shares were grounded after the Keurig and K-Cup company posted weaker-than-expected quarterly results.

ATP is facing mounting skepticism on its ability to meet rising bond yields. Despite its CFO's attempt to calm investors by pointing out that it has no intention of skipping any interest payments, one analyst downgraded the company's bonds on bankruptcy concerns.

It was a rough week for these five stocks. Let's see if they bounce back.

Motley Fool newsletter services have recommended buying shares of Green Mountain Coffee Roasters. Motley Fool newsletter services have recommended creating a lurking gator position in Green Mountain Coffee Roasters. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Longtime Fool contributor Rick Munarriz calls them as he sees them. He does not own shares in any of the stocks in this story. Rick is also part of the Rule Breakers newsletter research team, seeking out tomorrow's ultimate growth stocks a day early.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 1588797, ~/Articles/ArticleHandler.aspx, 7/31/2014 3:10:47 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement